Product - Concept - Mission
The solution we propose is called SENSY: a unique device worldwide, which allows amputees, unlike currently available prostheses, to feel again from missing limbs. It is a neuroprosthetic device, which will be implanted within the residual nerves (in amputees), or healthy part of the nerves (in the case of neuro-damaged subjects), restoring the natural-like flow of the neural sensory information. It will enable subjects to feel natural and complete sensations from the missing or non-functional limb.
Children who stepped over a mine, or people who were in a car accident, hit by drunken drivers, deserve the possibility to live a normal life. Bilateral amputees are unable to feel the touch of their children or texture of the beloved person’s skin. Amputees cannot perform basic manipulation tasks without complete attention, while more sophisticated ones are prohibitive. The prosthesis is a cumbersome foreign body causing also severe psychological problems, together with multiple problems during its control, which often result in its abandonment. People with severe nerve injuries often do not have any limb-functionality, and are even deciding to cut it, replacing it with limited commercial prosthesis.
Our mission is to restore complete functionality of upper and lower limb amputees, as well as those that had nerve-damage.
We are uniquely motivated group of dreamers, hard-workers and close friends, who have technical know-how and the first ever worldwide experience in this field. As a result of the long-standing research, we acquired the knowledge reflected in the first proof-of-concept clinical trial, a patent and a highly qualified team, with strong international reputation.
Meet the team behind the idea.
Francesco Maria Petrini
- Università Cattolica del Sacro Cuore, Rome, Italy
- The Clinical Centre of Serbia at Belgrade
- Centre hospitalier universitaire vaudois (CHUV), Lausanne, Switzerland
- Charité clinical center, Berlin
Technical and R&D Collaborations
- École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland
- Scuola Superiore Sant’Anna, Pisa, Italy
- Wyss Center for Bio and Neuro-Engineering, Campus Biotech, Geneva, Switzerland
AWARDS and prizes
Check out our latest news and stories
SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY
SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY, unique worldwide device to restore sensory feedback to leg amputees. The project is financed by the European Commission and is called GoSafe. More information can be found here.
SensArs financed from the European Commission to explore the feasibility of stimulating the vagal nerve
SensArs, within a consortium of 6 partners coming from 5 countries, was financed from the European Commission to explore the feasibility of stimulating the vagal nerve to control the heartbeat of patients who underwent heart transplantation. The project is called NeuHearth (Grant agreement ID: 824071). More information can be found here.
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018 – valued at €50,000 each – to accelerate their entry to market. Read here the news from EIT Health.
Click here to view full document.
“The venture leaders Life Science program is a one-week investors and business roadshow in Boston, co-organized with swissnex Boston. This year’s winners develop amazing technologies such as a prosthesis which allows amputees to naturally feel their missing limbs again or an ingeniously simple approach to computed guided needle navigation in the body.”
“The seventh edition of the TOP 100 Swiss startup ranking was disclosed on September 6th in front of 600 participants. The broad spectrum of innovative high-tech startups attracted dozens of investors from abroad, and even from Silivon Valley and China. Switzerland ranks as the most innovative nation according to the Global Innovation Index 2017. The TOP[…]
‘Four Swiss start-ups will receive CHF 50’000 each through the Horizon 2020 SME instrument scheme. The instrument, provided with about € 3 billion, is accessible to Swiss SMEs since January 2017. Next application deadline is 6 September.’
Sensars is featured on 101 innovative digital health, eHealth, mHealth startups in Switzerland list on Science Service (Dr. Hempel Digital Health Network) website. Check out the full list here.
The startup SensArs Neuroprosthetics restores feelings to amputees’ missing legs. In December 2016, the first prototype of SensArs’ product was successfully implanted by an international team of specialists. This medical device gets worldwide attention and wins CHF 130’000 of pre-seed capital at the Venture Kick final.
Following the evaluation of proposals submitted to the very first Future and Emerging Technologies (FET) Innovation Launchpad call, 16 successful proposals have now been invited to grant agreement preparation. The FET Innovation Launchpad aims at boosting economic growth stemming from FET research by supporting unexplored innovation opportunities from FET-funded projects.